DE69518164D1 - Verfahren zur herstellung von n-(amidinophenyl pyrrolidin)-n'-beta-alanin-substituierten harnstoffen - Google Patents

Verfahren zur herstellung von n-(amidinophenyl pyrrolidin)-n'-beta-alanin-substituierten harnstoffen

Info

Publication number
DE69518164D1
DE69518164D1 DE69518164T DE69518164T DE69518164D1 DE 69518164 D1 DE69518164 D1 DE 69518164D1 DE 69518164 T DE69518164 T DE 69518164T DE 69518164 T DE69518164 T DE 69518164T DE 69518164 D1 DE69518164 D1 DE 69518164D1
Authority
DE
Germany
Prior art keywords
beta
alanine
amidinophenyl
producing
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69518164T
Other languages
English (en)
Other versions
DE69518164T2 (de
Inventor
Anthony Abood
Lee Flynn
Anthony Laneman
Roger Nosal
Ann Schretzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of DE69518164D1 publication Critical patent/DE69518164D1/de
Publication of DE69518164T2 publication Critical patent/DE69518164T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69518164T 1994-12-05 1995-12-04 Verfahren zur herstellung von n-(amidinophenyl pyrrolidin)-n'-beta-alanin-substituierten harnstoffen Expired - Fee Related DE69518164T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/349,333 US5610296A (en) 1994-12-05 1994-12-05 Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs
PCT/US1995/014948 WO1996017827A1 (en) 1994-12-05 1995-12-04 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE β-ALANINE UREA ANALOGS

Publications (2)

Publication Number Publication Date
DE69518164D1 true DE69518164D1 (de) 2000-08-31
DE69518164T2 DE69518164T2 (de) 2001-03-22

Family

ID=23371935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69518164T Expired - Fee Related DE69518164T2 (de) 1994-12-05 1995-12-04 Verfahren zur herstellung von n-(amidinophenyl pyrrolidin)-n'-beta-alanin-substituierten harnstoffen

Country Status (11)

Country Link
US (4) US5610296A (de)
EP (1) EP0796245B1 (de)
JP (1) JPH10509960A (de)
AT (1) ATE194976T1 (de)
AU (1) AU4163696A (de)
DE (1) DE69518164T2 (de)
DK (1) DK0796245T3 (de)
ES (1) ES2150592T3 (de)
GR (1) GR3034516T3 (de)
PT (1) PT796245E (de)
WO (1) WO1996017827A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE261969T1 (de) * 1996-03-28 2004-04-15 Glaxo Group Ltd Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
ZA988469B (en) * 1997-09-17 1999-03-17 Biocryst Pharm Inc Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
ZA988735B (en) 1997-10-06 2000-03-23 Du Pont Pharm Co An efficient method for the conversion of nitriles to amidines.
US5986107A (en) * 1998-04-08 1999-11-16 G. D. Searle & Co. Process for the preparation of a 2-oxopyrrolidine compound
US6025358A (en) * 1998-06-11 2000-02-15 G. D. Searle & Co. Double prodrugs of potent GP IIb/IIIa antagonists
DE19841895A1 (de) * 1998-09-11 2000-03-23 Degussa Neues Verfahren zur Herstellung von 3-Amino-2-oxo-pyrrolidinen, neue Zwischenprodukte und deren Verwendung
ES2296625T3 (es) * 1999-05-07 2008-05-01 Encysive Pharmaceuticals, Inc Derivados del acido carboxilico que inhiben el enlace de las integrinas con sus receptores.
US6972296B2 (en) * 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
US6723711B2 (en) 1999-05-07 2004-04-20 Texas Biotechnology Corporation Propanoic acid derivatives that inhibit the binding of integrins to their receptors
SI21096B (sl) * 2001-10-09 2012-05-31 Encysive Pharmaceuticals Inc Derivati karboksilne kisline ki inhibirajo vezavo integrinov na njihove receptorje
WO2003055856A2 (en) 2001-10-17 2003-07-10 Bristol-Myers Squibb Company BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
WO2009032057A2 (en) 2007-08-29 2009-03-12 Adam Lubin Method for the selective therapy of disease
JP5977349B2 (ja) 2012-06-15 2016-08-24 田辺三菱製薬株式会社 芳香族複素環化合物
CN111440149A (zh) * 2020-03-31 2020-07-24 浙江美诺华药物化学有限公司 一种达比加群酯中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL55573A0 (en) * 1977-10-03 1978-12-17 Erba Carlo Spa Substituted n-(ss-alkoxy-ethyl)-n-(4-phenoxybenzyl)-dichloroacetamides and process for their preparation
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
AU681396B2 (en) * 1993-03-31 1997-08-28 G.D. Searle & Co. 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors

Also Published As

Publication number Publication date
DE69518164T2 (de) 2001-03-22
AU4163696A (en) 1996-06-26
ATE194976T1 (de) 2000-08-15
DK0796245T3 (da) 2000-09-11
JPH10509960A (ja) 1998-09-29
PT796245E (pt) 2000-12-29
GR3034516T3 (en) 2000-12-29
US5484946A (en) 1996-01-16
EP0796245A1 (de) 1997-09-24
WO1996017827A1 (en) 1996-06-13
EP0796245B1 (de) 2000-07-26
ES2150592T3 (es) 2000-12-01
US5659063A (en) 1997-08-19
US5610296A (en) 1997-03-11
US5576447A (en) 1996-11-19

Similar Documents

Publication Publication Date Title
DE69518164T2 (de) Verfahren zur herstellung von n-(amidinophenyl pyrrolidin)-n'-beta-alanin-substituierten harnstoffen
DK0582790T3 (da) Ny fremgangsmåde til fremstilling af 7-substituerede-9-[(substitueret glycyl)-amino]-6-demethyl-6-deoxytetracycliner
DE19882893T1 (de) Herstellung von 3-substituierten Adeninen
ATE410412T1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
ATE194348T1 (de) Verfahren zur herstellung von camptothecin und analogen camptothecinen
HUP9902576A1 (hu) Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben
DE3883456T2 (de) Verfahren zur Herstellung von substituierten Indolinonderivaten.
ATE236139T1 (de) Verfahren zur herstellung von 2-chlor-5- chlomethyl-thiazol-derivaten
ATE190614T1 (de) Dihydrat des n-(4-amino-6,7-dimethoxychinazol-2- yl)-n-methyl-n'-(tetrahydrofuroyl-2)- propylendiamin hydrochlorids(=alfuzosin hydrochlorid dihydrat) und ein verfahren zur herstellung
ATE407127T1 (de) Verfahren zur herstellung von beraprost und dessen salzen
DE69431824D1 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
DE69031623T2 (de) Thioacylierungsmittel und zwischenprodukte, thiopeptide, und verfahren zu deren herstellung und anwendung
ATE28858T1 (de) Derivate von n-(methoxyphenacyl)aminen, ihre therapeutische verwendung und verfahren zu ihrer herstellung.
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE59009951D1 (de) Verfahren zur Herstellung von Zwischenprodukten und zur Synthese von N-(2-Hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine.
ATE297893T1 (de) Verfahren zur herstellung von pyrrolidonen
DE69410073D1 (de) Verfahren zur Herstellung von 2-Perfluoroalkyl-3-oxazolin-5-one
DE69331792D1 (de) Verfahren zur Herstellung von 2-Oxopyrrolidinylacetamid-Derivaten
DE69707603D1 (de) Verfahren zur Herstellung von N2-Arylsulfonyl-L-Argininamiden
ATE227289T1 (de) Verfahren zur herstellung von azyklischen nukleosiden
ATE55768T1 (de) Substituierte alkylamino-derivate von 6,11dihydro-11-oxo-dibenz(b,e)-oxepin, verfahren zu ihrer herstellung, ihre zwischenprodukte und ihre verwendung als arzneimittel.
ATE1190T1 (de) Verfahren zur herstellung von n-substituierten acrylamiden.
ES8605472A1 (es) Procedimiento para la preparacion de derivados de 1-(n-(a- amino-a-metilacetil)-aminofenil)-2-amino-propanona

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee